A Comparison of Biological Therapies vs Traditional Immunosuppressant in the Management of Inflammatory Bowel Diseases: A Narrative Review. [PDF]
Tahir UF +11 more
europepmc +1 more source
Population frequencies of thiopurine-related pharmacogenes in healthy individuals from Kosovo. [PDF]
Pasha F +6 more
europepmc +1 more source
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting [PDF]
Beitelshees, AL +26 more
core +1 more source
A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities. [PDF]
Balarajah S +11 more
europepmc +1 more source
Adverse Events Related to Azathioprine Use in Patients With Inflammatory Bowel Disease: A Real-World Cohort Study. [PDF]
Ranjan MK +4 more
europepmc +1 more source
Management of Inflammatory Bowel Disease with History of Cancer. [PDF]
Annese V +7 more
europepmc +1 more source
NUDT5 regulates purine metabolism and thiopurine sensitivity by interacting with PPAT. [PDF]
Wu Z +26 more
europepmc +1 more source
Azathioprine co-therapy with allopurinol for inflammatory bowel disease: Trials and tribulations [PDF]
Ansari, Azhar R., Duley, John A.
core
Pharmacogenomics of Thiopurine Drugs: A Bench-To-Bedside Success Story in Thailand. [PDF]
Biswas M, John S, Murad MA, Sukasem C.
europepmc +1 more source
Personalized medicine to implementation science: Thiopurines set for the leap
Vishal Sharma +2 more
doaj +1 more source

